ArticleScientific reports2025
Characterization of adverse reactions to four common targeted drugs for hepatocellular carcinoma in WHO-VigiAccess.
Zeyu Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it